Dela Cerna, Nickson Skyler .

HRN: 25-74-76  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/04/2025
CLARITHROMYCIN 125MG/5ML, 60ML SUSPENSION (BOT)
01/04/2025
01/10/2025
PO
2.5ml
Q12h
PCAP C
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: